esketamine has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, D; Wang, H; Wang, Z; Wu, B; Yan, F; You, Y; Yuan, S; Zhang, F; Zhu, R; Zhu, X | 1 |
| du Jardin, K; Elfving, B; Liebenberg, N; Müller, HK; Sanchez, C; Wegener, G | 1 |
| Li, Y; Liu, JZ; Lv, JM; Miao, HT; Shan, YD; Song, RX; Wang, LY; Wu, ZY; Zhang, DX; Zhang, LM; Zhang, W | 1 |
| Du, Y; Liu, B; Liu, Q; Xu, C; Zhang, L | 1 |
| Chang, L; Dong, C; Fujita, Y; Hashimoto, K; Pu, Y; Qu, Y; Ren, Q; Wang, SM; Xiong, Z; Zhang, K | 1 |
| Elfving, B; Harvey, BH; Joca, SRL; Pereira, VS; Wegener, G | 1 |
6 other study(ies) available for esketamine and Disease Models, Animal
| Article | Year |
|---|---|
S-Ketamine Exerts Antidepressant Effects by Regulating Rac1 GTPase Mediated Synaptic Plasticity in the Hippocampus of Stressed Rats.
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder, Major; Disease Models, Animal; GTP Phosphohydrolases; Hippocampus; Ketamine; Neuronal Plasticity; rac1 GTP-Binding Protein; Rats; Stress, Psychological | 2023 |
Single dose S-ketamine rescues transcriptional dysregulation of Mtor and Nrp2 in the prefrontal cortex of FSL rats 1 hour but not 14 days post dosing.
Topics: Animals; Depression; Depressive Disorder, Major; Disease Models, Animal; Prefrontal Cortex; Rats; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2022 |
Subanesthetic dose of S-ketamine improved cognitive dysfunction via the inhibition of hippocampal astrocytosis in a mouse model of post-stroke chronic stress.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Gliosis; Hippocampus; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Stroke | 2023 |
Antidepressant effects of repeated s-ketamine administration as NMDAR Antagonist: Involvement of CaMKIIα and mTOR signaling in the hippocampus of CUMS mice.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Hippocampus; Receptors, Glutamate; Stress, Psychological; TOR Serine-Threonine Kinases | 2023 |
Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
Topics: Administration, Intranasal; Animals; Antidepressive Agents; Behavior, Animal; Depression; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Dose-Response Relationship, Drug; Ketamine; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Prepulse Inhibition; Receptors, N-Methyl-D-Aspartate; Saline Solution; Stress, Psychological | 2019 |
Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Imipramine; Ketamine; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Swimming; Treatment Outcome | 2019 |